Neural modulation for hypertension and heart failure

Hypertension (HTN) and heart failure (HF) have a significant global impact on health, and lead to increased morbidity and mortality. Despite recent advances in pharmacologic and device therapy for these conditions, there is a need for additional treatment modalities. Patients with sub-optimally treated HTN have increased risk for stroke, renal failure and heart failure. The outcome of HF patients remains poor despite modern pharmacological therapy and with established device therapies such as CRT and ICDs.

Source: International Journal of Cardiology - April 3, 2016 Category: Cardiology Authors: S. Smith, P. Rossignol, S. Willis, F. Zannad, R. Mentz, S. Pocock, J. Bisognano, Y. Nadim, N. Geller, S. Ruble, C. Linde Tags: Review Source Type: research